XBiotech Inc. (XBIT) stock
XBITNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.73−0.05 (-2.81%)
Close on Nov 18, 2026Market cap $52.74MP/E –Yield –
XBiotech gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
XBiotech's gross profit for the twelve months ending Dec 31, 2023 was $0, down 100.0% year over year. For fiscal 2023 it was $0, down 100.0% from the year before. The highest annual figure on record is $12.57M in fiscal 2021.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $0 | -100.0% |
| FY2022 | Dec 31, 2022 | $3.36M | -73.3% |
| FY2021 | Dec 31, 2021 | $12.57M | +33.1% |
| FY2020 | Dec 31, 2020 | $9.45M | – |
| FY2019 | Dec 31, 2019 | $0 | – |
| FY2018 | Dec 31, 2018 | $0 | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2023 | Dec 31, 2023 | $0 | -100.0% |
| Q3 FY2023 | Sep 30, 2023 | $0 | -100.0% |
| Q2 FY2023 | Jun 30, 2023 | $0 | -100.0% |
| Q1 FY2023 | Mar 31, 2023 | $0 | -100.0% |
| Q4 FY2022 | Dec 31, 2022 | $284.00K | -91.8% |
| Q3 FY2022 | Sep 30, 2022 | $1.47M | -57.0% |
| Q2 FY2022 | Jun 30, 2022 | $1.32M | -58.2% |
| Q1 FY2022 | Mar 31, 2022 | $287.00K | -88.7% |
| Q4 FY2021 | Dec 31, 2021 | $3.45M | +14.3% |
| Q3 FY2021 | Sep 30, 2021 | $3.41M | +203.6% |
| Q2 FY2021 | Jun 30, 2021 | $3.17M | +37.8% |
| Q1 FY2021 | Mar 31, 2021 | $2.55M | -15.3% |
| Q4 FY2020 | Dec 31, 2020 | $3.02M | – |
| Q3 FY2020 | Sep 30, 2020 | $1.12M | – |
| Q2 FY2020 | Jun 30, 2020 | $2.30M | – |
| Q1 FY2020 | Mar 31, 2020 | $3.01M | – |
| Q4 FY2019 | Dec 31, 2019 | $0 | – |
| Q3 FY2019 | Sep 30, 2019 | $0 | – |
| Q2 FY2019 | Jun 30, 2019 | $0 | – |
See a number that looks wrong?